alpha1-Antitrypsin issu du plasma humain, poudre lyophilisée sans sel

Code: a9024-5mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

1-4 mg will inhibit 1.0 mg of trypsin with activity of approx. 10,000 BAEE units per mg protein. 1-6 mg will inhibit 1.0 mg of α-chymotrypsin wit...


en savoir plus

Votre prix
£252.00 5MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

1-4 mg will inhibit 1.0 mg of trypsin with activity of approx. 10,000 BAEE units per mg protein. 1-6 mg will inhibit 1.0 mg of α-chymotrypsin with activity of >=40 BTEE units per mg protein.

Serine protease inhibitor; inhibits trypsin, chymotrypsin and pancreatic and granulocytic elastase, and acrosin. Effective concentration equimolar with proteinase.The effects of hereditary α1-antitrypsin deficiency and certain autoimmune states result from uncontrolled proteolysis in vivo. Direct α1-antitrypsin replacement therapy has shown promise in animal models of Type 1 diabetes.

Caution

Aqueous stock solutions containing 0.01% NaN3 are stable for several months. Solutions can be stored at −80 °C, but should not be refrozen. Unstable below pH 5.5. Inactivated by some non-serine proteinases and by oxidation of active site methionine residue.

Packaging

5, 25 mg in glass bottle

Preparation Note

Chromatographically prepared and partially purified.

assay≥70% protein basis (biuret)
biological sourcehuman plasma
formsalt-free, lyophilized powder
Gene Informationhuman ... ELA2(1991), SERPINA1(5265)
Quality Level200
storage temp.2-8°C
UniProt accession no.P01009, P08246
Code
Description
Unité de vente
Prix annoncé
Qté
A9024-25MG
Unité:25MG
Prix annoncé: £997.00
Source:Prix annoncé
Cas Number9041-92-3
Ce produit répond aux critères suivants: